UBS Group’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.9M | Buy |
514,753
+32,646
| +7% | +$1.2M | ﹤0.01% | 1893 |
|
|
2025
Q1 | $17M | Buy |
482,107
+182,324
| +61% | +$6.45M | ﹤0.01% | 1928 |
|
|
2024
Q4 | $13.1M | Buy |
299,783
+106,704
| +55% | +$4.67M | ﹤0.01% | 2117 |
|
|
2024
Q3 | $8.76M | Sell |
193,079
-24,684
| -11% | -$1.12M | ﹤0.01% | 1781 |
|
|
2024
Q2 | $8.45M | Sell |
217,763
-87,216
| -29% | -$3.38M | ﹤0.01% | 1722 |
|
|
2024
Q1 | $9.83M | Sell |
304,979
-1,579
| -0.5% | -$50.9K | ﹤0.01% | 1625 |
|
|
2023
Q4 | $8.79M | Buy |
306,558
+209,399
| +216% | +$6.01M | ﹤0.01% | 1552 |
|
|
2023
Q3 | $2.69M | Sell |
97,159
-39,295
| -29% | -$1.09M | ﹤0.01% | 2320 |
|
|
2023
Q2 | $3.65M | Sell |
136,454
-1,907
| -1% | -$51K | ﹤0.01% | 2157 |
|
|
2023
Q1 | $3M | Sell |
138,361
-29,282
| -17% | -$634K | ﹤0.01% | 2242 |
|
|
2022
Q4 | $3.99M | Buy |
167,643
+134,940
| +413% | +$3.21M | ﹤0.01% | 2015 |
|
|
2022
Q3 | $645K | Sell |
32,703
-8,329
| -20% | -$164K | ﹤0.01% | 3176 |
|
|
2022
Q2 | $800K | Sell |
41,032
-49,117
| -54% | -$958K | ﹤0.01% | 3031 |
|
|
2022
Q1 | $2.3M | Sell |
90,149
-24,271
| -21% | -$619K | ﹤0.01% | 2553 |
|
|
2021
Q4 | $2.88M | Sell |
114,420
-2,930
| -2% | -$73.7K | ﹤0.01% | 2585 |
|
|
2021
Q3 | $3.23M | Buy |
117,350
+116,252
| +10,588% | +$3.2M | ﹤0.01% | 2390 |
|
|
2021
Q2 | $35K | Sell |
1,098
-340
| -24% | -$10.8K | ﹤0.01% | 5698 |
|
|
2021
Q1 | $66K | Buy |
1,438
+235
| +20% | +$10.8K | ﹤0.01% | 5287 |
|
|
2020
Q4 | $48K | Buy |
+1,203
| New | +$48K | ﹤0.01% | 5232 |
|
|
2020
Q3 | – | Sell |
-4,892
| Closed | -$154K | – | 7345 |
|
|
2020
Q2 | $154K | Sell |
4,892
-3,479
| -42% | -$110K | ﹤0.01% | 4188 |
|
|
2020
Q1 | $183K | Buy |
+8,371
| New | +$183K | ﹤0.01% | 3957 |
|